Neuronetics Company
Neuronetics develops non-invasive therapies for psychiatric and neurological disorders.
Estimated Revenue:
$10M to $50M
Funding Status:
IPO
Industry:
Biotechnology, Health Care, Medical Device, Therapeutics
Investors Number:
15
Last Funding Date:
2021
Number Of Exists:
N/A
Technology:
Neuromodulation
Founded Date:
2003
Investor Type:
N/A
Headquarters:
Malvern, Pennsylvania, United States
Total Funding:
248400000
Last Funding Type:
Post-IPO Equity
Employee Number:
101-250
Investment Stage:
N/A